# Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations

> **NCT06367205** · NA · RECRUITING · sponsor: **RenJi Hospital** · enrollment: 380 (estimated)

## Conditions studied

- Delayed Graft Function
- End Stage Renal Disease
- Kidney Transplantation

## Interventions

- **DRUG:** Goal-Directed Fluid Therapy (GDFT)
- **DRUG:** Regular Fluid Therapy

## Key facts

- **NCT ID:** NCT06367205
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 380 (ESTIMATED)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06367205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06367205, "Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT06367205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*